Delisting riskPopularity #4,494
Bioceres Crop Solutions (BIOX)
Commercializes seed, microbial, nutrition, and crop-protection products for agricultural production.
$0.3781
vs last close+0.02 (+5.06%)
In millions of USD, except per-share figures
| In millions | Q1 FY24Sep 2023 | Q2 FY24Dec 2023 | Q3 FY24Mar 2024 | Q4 FY24Jun 2024 | Q1 FY25Sep 2024 | Q2 FY25Dec 2024 | Q3 FY25Mar 2025 | Q4 FY25Jun 2025 | Q1 FY26Sep 2025 | Q2 FY26Dec 2025 | Q3 FY26Mar 2026 | Q4 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 116 | 140 | 84 | 124 | 93 | 99 | 60 | 74 | 77 | 74 | 38 | 57 |
| Cost of revenue | 73 | 89 | 41 | 83 | 55 | 58 | 36 | 51 | 42 | 47 | 27 | 43 |
| Gross profit | 44 | 52 | 43 | 42 | 37 | 41 | 23 | 23 | 36 | 26 | 12 | 14 |
| 39 | 35 | 29 | 32 | 34 | 26 | 23 | 30 | 28 | 18 | 18 | 24 | |
| Research & development | 5 | 4 | 4 | 5 | 4 | 2 | 4 | 3 | 6 | 2 | 0 | 0 |
| 27 | 31 | 31 | 23 | 21 | 17 | 21 | 23 | 17 | 13 | 0 | 24 | |
| Selling & marketing | 5 | 1 | 1 | 4 | 4 | 3 | 4 | 4 | 2 | 3 | 0 | 0 |
| General & administrative | 22 | 30 | 30 | 19 | 17 | 14 | 17 | 18 | 14 | 10 | 0 | 0 |
| Other expenses | −1 | 0 | −5 | 4 | 8 | 7 | −2 | 5 | 6 | 4 | 18 | 0 |
| Operating income | 5 | 17 | 13 | 9 | 4 | 15 | 1 | −7 | 8 | 8 | −7 | −10 |
| −8 | −7 | −4 | −16 | −11 | −8 | −7 | −38 | −13 | −9 | −11 | −20 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 7 | 7 | 4 | 7 | 6 | 5 | 6 | 7 | 9 | 7 | 7 | 20 |
| Other non-operating income | 1 | 2 | 1 | 0 | 5 | 3 | 0 | 31 | 5 | 2 | 0 | 0 |
| Income before tax | −2 | 10 | 9 | −6 | −7 | 7 | −6 | −45 | −5 | −1 | −18 | −30 |
| Income tax expense | 0 | 8 | −1 | −4 | −1 | 1 | −4 | 7 | 2 | 3 | −4 | 2 |
| Net income from continuing operations | −3 | 1 | 10 | −2 | −6 | 7 | −2 | −52 | −7 | −4 | −14 | −32 |
| Discontinued operations | 0 | 0 | 0 | 0 | 0 | −6 | 0 | 0 | 0 | −178 | 0 | 1 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −5 | 0 | 9 | −2 | −6 | 0 | −1 | −48 | −7 | −183 | −12 | −28 |
| EPS, basic | −$0.07 | $0.00 | $0.15 | −$0.03 | −$0.09 | $0.00 | −$0.02 | −$0.70 | −$0.12 | −$2.88 | −$0.19 | −$0.39 |
| EPS, diluted | −$0.07 | $0.00 | $0.14 | −$0.03 | −$0.09 | $0.00 | −$0.02 | −$0.70 | −$0.12 | −$2.88 | −$0.19 | −$0.39 |
| Weighted average shares, basic | 63 | 63 | 63 | 61 | 63 | 63 | 63 | 63 | 63 | 63 | 64 | 64 |
| Weighted average shares, diluted | 63 | 64 | 67 | 61 | 63 | 63 | 63 | 63 | 63 | 63 | 64 | 64 |
| EBITDA | 10 | 20 | 20 | 9 | 4 | 14 | 7 | −33 | 9 | 7 | −3 | −10 |
| Depreciation & amortization | 5 | 5 | 5 | 7 | 5 | 1 | 6 | 5 | 6 | 1 | 3 | 0 |
| EBIT | 5 | 15 | 15 | 2 | −1 | 13 | 1 | −38 | 3 | 6 | −7 | −10 |